Thiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients With High-Risk Acute Myeloid Leukemia

NCT06869265 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia (AML)
High Risk Acute Myeloid Leukemia(AML)
Relapsed/Refractory Acute Myeloid Leukemia (AML)

Interventions

DRUG: Thiotepa ;busulfan;fludarabine

Sponsor

Peking University People's Hospital